Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:41 pm Sale |
2023-02-13 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 11,419,226 16.950% |
-3,111,770 (-21.41%) |
Filing History |
| 2023-02-10 4:40 pm Purchase |
2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
BLACKROCK INC BLK |
5,329,830 7.900% |
327,467 (+6.55%) |
Filing |
| 2023-02-10 4:05 pm Purchase |
2022-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Weiss Asset Management LP | 7,457,060 11.090% |
1,299,700 (+21.11%) |
Filing History |
| 2023-02-09 11:35 am Sale |
2022-12-30 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 5,558,839 8.250% |
-740,984 (-11.76%) |
Filing History |
| 2023-01-30 3:06 pm Purchase |
2023-01-11 | 13G | Theravance Biopharma, Inc. TBPH |
Barclays PLC | 3,402,767 5.050% |
3,402,767 (New Position) |
Filing History |
| 2022-09-20 4:12 pm Sale |
2022-09-16 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 0 0.000% |
-9,644,807 (Position Closed) |
Filing History |
| 2022-08-03 08:33 am Unchanged |
2022-08-03 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 12.700% |
0 (Unchanged) |
Filing History |
| 2022-06-16 3:41 pm Purchase |
2022-06-08 | 13G | Theravance Biopharma, Inc. TBPH |
Weiss Asset Management LP | 6,157,360 8.090% |
6,157,360 (New Position) |
Filing History |
| 2022-04-21 11:08 am Purchase |
2022-03-18 | 13G | Theravance Biopharma, Inc. TBPH |
ODRE 2005 SLU | 4,108,318 5.500% |
4,108,318 (New Position) |
Filing History |
| 2022-02-14 4:40 pm Sale |
2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Point72 Asset Management, L.P. | 228,922 0.300% |
-4,915,715 (-95.55%) |
Filing History |
| 2022-02-14 09:43 am Purchase |
2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Madison Avenue International LP | 6,648,025 9.000% |
2,080,612 (+45.55%) |
Filing History |
| 2022-02-11 4:49 pm Sale |
2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
ORBIMED ADVISORS LLC | 5,456,780 7.400% |
-87,432 (-1.58%) |
Filing History |
| 2022-02-11 4:15 pm Purchase |
2022-02-11 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 14,530,996 19.490% |
4,925,000 (+51.27%) |
Filing History |
| 2022-02-10 4:48 pm Unchanged |
2021-11-08 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 13.100% |
0 (Unchanged) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 6,299,823 8.550% |
1,645,514 (+35.35%) |
Filing History |
| 2022-02-03 4:29 pm Purchase |
2021-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
BLACKROCK INC BLK |
5,002,363 6.800% |
511,168 (+11.38%) |
Filing |
| 2021-10-12 09:25 am Sale |
2021-10-08 | 13G | Theravance Biopharma, Inc. TBPH |
FMR CORP | 2,670,881 3.635% |
-6,936,429 (-72.20%) |
Filing History |
| 2021-10-08 08:36 am Sale |
2021-09-30 | 13G | Theravance Biopharma, Inc. TBPH |
WELLINGTON MANAGEMENT CO LLP | 250,219 0.340% |
-7,352,526 (-96.71%) |
Filing History |
| 2021-09-27 4:46 pm Purchase |
2021-09-15 | 13G | Theravance Biopharma, Inc. TBPH |
Madison Avenue International LP | 4,567,413 6.200% |
4,567,413 (New Position) |
Filing History |
| 2021-09-07 4:35 pm Purchase |
2021-08-25 | 13G | Theravance Biopharma, Inc. TBPH |
Point72 Asset Management, L.P. | 5,144,637 7.000% |
5,144,637 (New Position) |
Filing History |